Agence de la biomédecine - Homepage
  • Go to content

  • Press

  • Biomed meetings

  • International actions

  • Join us

Agence de la biomédecine - Homepage

Home > Medical genetics and testing > Recommendations for good practice "Use of maternal serum markers during pregnancy to calculate the risk of trisomy 21"

Recommendations for good practice "Use of maternal serum markers during pregnancy to calculate the risk of trisomy 21"

Published on 6 May 2025

Best practices / Recommendations
    Download documentPDF 65.48ko

      Share

      • Share on Twitter
      • Share on Linkedin
      • Share on Facebook
      • Share on Mail